FTISADTSK is an endogenous stable signature peptide associated with Trastuzumab, serving as a valuable biomarker for monitoring therapeutic response. This peptide can be utilized in selected reaction monitoring (SRM) assays, facilitating quantitative analysis in oncology research. Its application extends to studies focused on trastuzumab treatment efficacy and patient stratification in breast cancer therapies.
FTISADTSK is an endogenous stable signature peptide associated with Trastuzumab, serving as a valuable biomarker for monitoring therapeutic response. This peptide can be utilized in selected reaction monitoring (SRM) assays, facilitating quantitative analysis in oncology research. Its application extends to studies focused on trastuzumab treatment efficacy and patient stratification in breast cancer therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: